Last updated: January 9, 2025
Sponsor: Johns Hopkins University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Disease
Heart Defect
Cardiac Ischemia
Treatment
N/AClinical Study ID
NCT00181233
NA_00037404
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Left ventricular ejection fraction <or = 35%
Planned implantable cardioverter-defibrillator (ICD) implantation for clinicalindications (primary prevention)
Exclusion
Exclusion Criteria:
History of sudden death (secondary prevention)
Contraindication to undergoing MRI (metallic implant, pacemaker, etc.)
Study Design
Total Participants: 400
Study Start date:
October 01, 2003
Estimated Completion Date:
July 31, 2029
Study Description
Connect with a study center
Johns Hopkins Medical Institutions
Baltimore, Maryland 21287
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.